-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target

Benzinga·04/24/2025 11:05:36
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $102 price target.